SCHEMBL5738593

SCHEMBL5738593

O=C(CN1CCCCCC1=O)c1ccc(Br)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.62
HTT P42858 3/20 0.62
MAPT P10636 2/20 0.62
RAB9A P51151 2/20 0.62
ALDH1A1 P00352 5/20 0.46
GSK3B P49841 2/20 0.46
HPGD P15428 2/20 0.45
TSHR P16473 2/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
MAPK1 P28482 1/20 0.45
CYP2C19 P33261 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.44
NPC1 O15118 1/20 0.44
USP2 O75604 1/20 0.43
GLA P06280 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
ALOX12 P18054 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5739984 0.94 RAB9A (0.69) SMN1; SMN2HTTMAPTRAB9AALDH1A1
SCHEMBL7447238 0.82 TNF (0.48) SMN1; SMN2HTTMAPTRAB9AALDH1A1
SCHEMBL24634980 0.79 PKM (0.56) SMN1; SMN2HTTMAPTRAB9AALDH1A1
SCHEMBL5738542 0.79 ALDH1A1 (0.54) SMN1; SMN2HTTMAPTRAB9AALDH1A1
SCHEMBL5739537 0.79 RAB9A (0.69) SMN1; SMN2HTTMAPTRAB9AALDH1A1
SCHEMBL10418997 0.78 HTT (0.63) SMN1; SMN2HTTMAPTRAB9AALDH1A1
SCHEMBL1002669 0.76 ALDH1A1 (0.67) SMN1; SMN2HTTMAPTRAB9AALDH1A1
SCHEMBL16891466 0.74 L3MBTL1 (0.70) SMN1; SMN2ALDH1A1GSK3BHPGDL3MBTL1
SCHEMBL16563423 0.72 TRPV1 (0.48) SMN1; SMN2HTTMAPTRAB9AALDH1A1
SCHEMBL12070024 0.72 DGAT1 (0.44) SMN1; SMN2HTTMAPTRAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648447-A1 PYRAZOLINES AS PAR-1 ANTAGONISTS FOR TREATMENT OF CARDIOVASCULAR DISEASES Bayer HealthCare AG (DE) 2006-04-26 EP disclosed
WO-2005007157-A1 PYRAZOLINES AS PAR-1 ANTAGONISTS FOR TREATMENT OF CARDIOVASCULAR DISEASES BAYER HEALTHCARE AG (DE) 2005-01-27 WO disclosed